Table 2.

Clinicopathologic features and follow-up data

No.	Age (years)	Sex	Sites	Size (cm)	Grading*	therapy	Follow-up (months)
1	61	M	NC	1 × 1 × 1	II	S	Lost
2	63	M	NC and PNS	8 × 5 × 1	II	S	Lost
3	32	M	NC and PNS	2 × 2 × 2	II	S	Lost
4	60	F	Lung	4.3 × 3.5 × 1.5	I	S	Lost
5	47	M	NC	0.5 × 0.5 × 0.5	I	S	ANED	123
6	53	M	NC	1 × 1 × 1	I	S	Lost
7	55	F	NC and PNS	5 × 3 ×1.5	I	S+RT+C	AWD	110
8	62	F	Chest wall	11 × 1 0	I	S	Lost
9	63	M	Tonsil	3.5 × 3 × 2	I	S	AWD	97
10	54	M	NP	2 × 2 × 1	I	S	Lost
11	46	M	Occiput	8 × 6 × 3	I	S	Lost
12	49	F	NC	1.5 × 1 ×0.2	II	S	Lost
13	48	M	NC	1.5 × 1 ×0.6	III	S	Died	?
14	58	M	NC and PNS	6 × 4 × 1	III	S	ANED	81
15	32	M	PNS	4.5 × 4 × 1.5	II	S	AWD	92
16	47	M	trunk (back)	20 × 1 5 × 1 0	I	S	AWD	75
17	34	M	NC and PNS	3 × 3 ×1	I	S	Lost
18	50	F	NC	1 × 1 ×1	III	S	Lost
19	66	F	NP	0.5 × 0.5 × 0.5	I	S+RT	ANED	65
20	77	M	Cervical	2 × 1.5 × 0.8	I	S	Lost
21	35	M	NC and PNS	6 × 5 × 3	II	S	Lost
22	47	M	NC and PNS	3 × 3 × 2	II	S	DOD	17
23	55	M	PNS	2 × 1.6 × 0.6	I	S	Died	?
24	63	M	PNS	3 × 1.6 × 0.8	I	S	DOD	51
25	67	F	gum	1.5 × 1.2 × 1	II	S	Lost
26	65	M	cervicum	1 × 1 ×0.7	I	S	Lost
27	85	F	forehead	2 × 1.4 × 1	I	S	DOD	11
28	56	M	PNS	6 × 5 × 1	III	S	DOD	228
29	30	M	testis	3.5 × 3 × 2	II	S	Lost
30	56	M	NC	1 × 1 × 0.3	I	S	ANED	17
31	35	F	tonsil	1 × 1 × 1	I	S	AWD	6
32	59	F	PNS	5 × 4 × 3	II	S+RT	Lost

M = male; F = female;

*Grading, according to Bartl et al. RT = Radiotherapy;

AWD = alive with disease; DOD = died of disease;

ANED = alive with no evidence of disease; NC = nasal cavity;

S = surgery; NP = nasopharynx;

C = chemotherapy; PNS = paranasal sinus.

R = relapse